12.000
+30,43%
2026-09-09
Fundamental Analysis
48 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -11.8% | +108.9% | 2 / 3 | +44.3% | +0.57 pp | -0.30 pp | +11.8% | 1.55 | 8.47 | 2.260 | +44,3% | 10,6 | −11,6% | 8.47 | 14.85 | −43,0% |
| Pts | 0 | 12 | 8 | 12 | 8 | 4 | 0 | -4 | 12 | |||||||
Valuation annotation:Price: 12.000 (close price on 2026-09-09)EPS (TTM): 1.417
Financial charts
1.Revenue & growth
VND bn2.260Q2/26
1.Revenue & growth
VND bn2.260Q2/26
2.Profit & growth
VND bn10,5Q2/26
3.Profit mix (Penman)
VND bn62,3Q2/26
4.Margins & cost structure
%4.6%Q2/26
5.Returns & cash cycle
% · days4.6%Q2/26
6.Earnings quality & cash
VND bn34,3Q2/26
7.Asset structure
VND bn1.302Q2/26
8.Funding & debt health
VND bn · times1.302Q2/26
9.Revenue backlog
VND bn55,4Q2/26
10.Valuation
times · %8,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %289Q2/26
Adjusted EPS growth, latest quarter
-11.8%
Average adjusted EPS growth, 3 quarters
66.8%
averaged over 2 quarter(s)
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26